Unknown

Dataset Information

A case series report on successful management of patients with COVID-19-associated lymphopenia and potential application of PG2.


ABSTRACT:

Background

Lymphopenia and the resultant high neutrophil-to-lymphocyte ratio (NLR) are hallmark signs of severe COVID-19, and effective treatment remains unavailable. We retrospectively reviewed the outcomes of COVID-19 in a cohort of 26 patients admitted to Chung Shan Medical University Hospital (Taichung City, Taiwan). Twenty-five of the 26 patients recovered, including 9 patients with mild/moderate illness and 16 patients with severe/critical illness recovered. One patient died after refusing treatment.

Case presentation

We report the cases of four patients with high NLRs and marked lymphopenia, despite receiving standard care. A novel injectable botanical drug, PG2, containing Astragalus polysaccharides, was administered to them as an immune modulator. The decreas

SUBMITTER: Wang WY 

PROVIDER: S-EPMC9671954 | biostudies-literature | 2022

REPOSITORIES: biostudies-literature